fluorouracil has been researched along with Molluscum Contagiosum in 2 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Molluscum Contagiosum: A common, benign, usually self-limited viral infection of the skin and occasionally the conjunctivae by a poxvirus (MOLLUSCUM CONTAGIOSUM VIRUS). (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Warts and molluscum contagiosum are common skin diseases in children and are usually self-limiting." | 2.43 | How and when to treat molluscum contagiosum and warts in children. ( Smolinski, KN; Yan, AC, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhattacharjee, R | 1 |
Kumaran, MS | 1 |
Vinay, K | 1 |
Smolinski, KN | 1 |
Yan, AC | 1 |
1 review available for fluorouracil and Molluscum Contagiosum
Article | Year |
---|---|
How and when to treat molluscum contagiosum and warts in children.
Topics: Adhesives; Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Cantharidin; Child; Cim | 2005 |
1 other study available for fluorouracil and Molluscum Contagiosum
Article | Year |
---|---|
Intralesional 5-fluorouracil to treat extensive molluscum contagiosum in an immunocompromised patient: A novel therapeutic modality.
Topics: Antimetabolites; Facial Dermatoses; Female; Fluorouracil; HIV Infections; Humans; Immunocompromised | 2018 |